Your browser doesn't support javascript.
loading
Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial.
Leroux-Roels, Geert; Cramer, Jakob P; Mendelman, Paul M; Sherwood, James; Clemens, Ralf; Aerssens, Annelies; De Coster, Ilse; Borkowski, Astrid; Baehner, Frank; Van Damme, Pierre.
Afiliação
  • Leroux-Roels G; Center for Vaccinology, Ghent University and University Hospital, Belgium.
  • Cramer JP; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
  • Mendelman PM; Takeda Vaccines Inc, Boston, Massachusetts.
  • Sherwood J; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
  • Clemens R; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
  • Aerssens A; Center for Vaccinology, Ghent University and University Hospital, Belgium.
  • De Coster I; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Belgium.
  • Borkowski A; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
  • Baehner F; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
  • Van Damme P; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Belgium.
J Infect Dis ; 217(4): 597-607, 2018 01 30.
Article em En | MEDLINE | ID: mdl-29140444

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Virais / Infecções por Caliciviridae / Anticorpos Antivirais Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Virais / Infecções por Caliciviridae / Anticorpos Antivirais Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article